(KallR)Ubiquitin(Untagged)(human)(recombinant);BML-UW0205-1000原装正品
BML-UW0205-1000 1 mg
Product Specification
Purity Detail: Purified by perchloric acid treatment of a soluble lysate, followed by gradient elution from a cation exchange column.
MW: ~8.7kDa
Purity: ≥95% (SDS-PAGE) (Coomassie staining)
Sequence: H-MQIFVRTLTGRTITLEVEPSDTIENVRARIQDREGIPPDQQ RLIFAGRQLEDGRTLSDYNIQRESTLHLVLRLRGG-OH
Formulation: White lyophilized solid.
Source/Host: Produced in E. coli.
Reconstitution: Reconstitute with aqueous buffers or DMSO.
Shipping: SHIPPED ON BLUE ICE
Short Term Storage: -20°C
Long Term Storage: -20°C
Use/Stability: Store solid at –20°C for up to twelve months. Store solutions at –20°C for up to three months.
Miscellaneous/General: [KallR]Ubiquitin contains no lysine, with all seven lysines present in the wild type mutated to arginine (see sequence). These mutations render ubiquitin unable to form multi-ubiquitin chains and thus provide a useful negative control for poly-ubiquitinylation experiments. The ability of [KallR]ubiquitin to form an active thioester at the C-terminus is preserved, thus enabling [KallR]ubiquitin to be transferred to the lysines of substrate proteins, as is its ability to form linear N-terminal linkages to other ubiquitin molecules. It may also be used as an ubiquitin chain terminator.
订购电话:021-51870956
在线QQ：470003480
快来www.haoranbio.com体验在线订购给您带来的快捷和方便吧!
Product Specification
Purity Detail: Purified by perchloric acid treatment of a soluble lysate, followed by gradient elution from a cation exchange column.
MW: ~8.7kDa
Purity: ≥95% (SDS-PAGE) (Coomassie staining)
Sequence: H-MQIFVRTLTGRTITLEVEPSDTIENVRARIQDREGIPPDQQ RLIFAGRQLEDGRTLSDYNIQRESTLHLVLRLRGG-OH
Formulation: White lyophilized solid.
Source/Host: Produced in E. coli.
Reconstitution: Reconstitute with aqueous buffers or DMSO.
Shipping: SHIPPED ON BLUE ICE
Short Term Storage: -20°C
Long Term Storage: -20°C
Use/Stability: Store solid at –20°C for up to twelve months. Store solutions at –20°C for up to three months.
Miscellaneous/General: [KallR]Ubiquitin contains no lysine, with all seven lysines present in the wild type mutated to arginine (see sequence). These mutations render ubiquitin unable to form multi-ubiquitin chains and thus provide a useful negative control for poly-ubiquitinylation experiments. The ability of [KallR]ubiquitin to form an active thioester at the C-terminus is preserved, thus enabling [KallR]ubiquitin to be transferred to the lysines of substrate proteins, as is its ability to form linear N-terminal linkages to other ubiquitin molecules. It may also be used as an ubiquitin chain terminator.
订购电话:021-51870956
在线QQ：470003480
快来www.haoranbio.com体验在线订购给您带来的快捷和方便吧!